Dillione Janet 4

What Happened
Janet Dillione, a director of CorMedix Inc., was granted 30,453 restricted stock units (RSUs) on January 26, 2026. The Form 4 reports the award as an acquisition (code A) at $0.00 per unit (total reported value $0). Each RSU represents the right to receive one share of CorMedix common stock and will vest in full on January 26, 2027, subject to continued service on the vesting date.

Key Details

• Transaction date: 2026-01-26; Form 4 filed: 2026-01-27 (appears timely).
• Transaction type/code: Grant/Award (A).
• Units granted: 30,453 RSUs; reported price: $0.00; reported aggregate value: $0.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: RSUs convert to one share each and will vest in full on 2027-01-26 subject to continued service; no tax-withholding or sale-to-cover was reported.

Context
RSU grants are a form of equity compensation that give the recipient the right to receive shares in the future if vesting conditions are met; they are not an immediate purchase or sale of stock. Director awards are common as part of compensation and do not, by themselves, indicate a buy or sell signal.